Bioscience Pro

Bioscience Pro specializes in software documentation, verification, validation, and risk management for medical device manufacturers seeking FDA 510(k) clearance. The firm focuses on creating compliant documentation per IEC 62304, ISO 14971, and AAMI TIR 57 standards, enabling device companies to maintain focus on innovation while ensuring regulatory readiness.

The company's approach integrates with existing engineering teams to create live documentation that remains current throughout the development lifecycle. Services span the full documentation spectrum including system and software requirement specifications, software architectural design, hazards analysis, cybersecurity risk management, and traceability documentation. Bioscience Pro has documented over 500,000 lines of code and maintains a record of zero rejected FDA 510(k) submissions.

The firm serves medical device startups and established manufacturers across diagnostic testing, telehealth, imaging systems, and therapeutic devices. Additionally, Bioscience Pro provides due diligence services to investors evaluating medical device startups' regulatory readiness and 510(k) submission preparedness.

Choose Bioscience Pro when FDA 510(k) software documentation represents a critical path dependency and regulatory risk that could delay market entry or jeopardize fundraising. The firm's perfect submission record and ability to integrate with engineering teams makes them particularly valuable for startups balancing innovation velocity with regulatory compliance.

Expect a consultative engagement where Bioscience Pro staff work alongside your development team to create documentation that satisfies FDA requirements while remaining synchronized with actual software development. The firm's investor due diligence services also provide value for venture-backed companies needing third-party validation of regulatory readiness.

Bioscience Pro operates exclusively in medical device regulatory compliance, specifically targeting manufacturers of software-driven diagnostic, therapeutic, and monitoring devices. Their healthcare focus centers on FDA-regulated medical devices with documented experience across point-of-care diagnostics (COVID testing platforms), telehealth vital signs monitoring, medical imaging (CT/MRI processing, breast tumor diagnostics), glucose management systems, and proton therapy systems.

The firm's healthcare specialization extends to investor services, helping venture capital and private equity firms assess medical device startups' regulatory readiness and 510(k) submission timelines—addressing a critical due diligence gap in healthcare technology investments.

Medical device companies developing Class II devices with significant software components pursuing FDA 510(k) clearance through traditional or special pathways. Best fit for startups and growth-stage companies that have strong engineering capabilities but lack specialized regulatory documentation expertise, particularly those in diagnostics, digital therapeutics, or connected medical devices where software represents core functionality.